Doctor Thira reveals the results of a study of “Ivermectin”, can it really prevent severe illness in people infected with the coronavirus?

Dr Thira reveals that foreign studies have found that Ivermectin does not reduce the risk of severe illness in those infected with COVID-19 who sleep in ICU, use a ventilator and die.

Today (19 Feb. 65) Assoc. Prof. Dr. Teera Woratanarat Faculty of Medicine Chulalongkorn University Post a comment about the COVID situation. via Facebook Thira Woratanarat

by stating that “passed 421 million

Yesterday around the world, 1,868,169 more people died, 9,679 more deaths, totaling 421,890,616 people, 5,891,244 deaths.

The top five with the most infections were Germany, Russia, Brazil, South Korea and Japan.

The number of new infections every day in the world now. They come from Asia, Europe and North/South America. which together accounted for 98% of the world’s population, while the number of deaths accounted for 95.05%.

Recently, the number of new infections from Europe accounted for 50.85 percent of the world, while the number of deaths rose to 37.4 percent.

Yesterday, the number of new infections had countries from Europe and Asia occupy eight of the top 10 and 16 of the world’s top 20.

…Looking at the outbreak of the world

Worldometer data show that weekly new infections worldwide have dropped 21%, a marked downtrend. And the number of weekly deaths was down 7%.

However, only Asia and Oceania The number of weekly new infections dropped below the global average of 11% and 8%, respectively, indicates that the outbreak is continuing. and also heavier than other continents

There are 14 countries in Asia with weekly new infections that tend to increase. including our Thai

in depth in Thailand There was a 38% increase in weekly new infections and a 28% increase in deaths.

…update research

Ivermectin is ineffective in preventing serious illness in people with COVID-19. with mild to moderate symptoms

Lim SCL and team from Malaysia Published in the International Journal of Medicine, JAMA Internal Medicine, February 18, 2022. An open label randomized controlled trial was conducted in 20 hospitals and one detention facility from May 31 to October 25, 2021 in adults. sick with COVID-19 with mild to moderate symptoms aged 50 years and over, a total of 490 persons

They were divided into groups that received standard care. Compared with the standard treatment group plus ivermectin at a dose of 0.4 mg/kg of body weight for 5 days and assessed for the incidence of severe morbidity, morbidity, ventilatory support, and death at 28 days of rupture. different or not

The study found that ivermectin did not help in reducing the risk of severe illness, intensive care, ventilator use, and death.

…for Thailand now The epidemic continues to be severe, widespread. The infection is highly contagious both at home and at work, as well as during everyday life when socializing with others.

Strict, routine self-defense is essential. always wear a mask distance from others Meet other people as needed. Take a short time. Avoid eating, drinking, or sharing food with others. and if you are sick should stop studying notify close ones Go for a checkup to get better first. It is a responsibility to oneself, family and society.”

Picture from AFP/Archyde.com/Thira Woratanarat

Leave a Comment

This site uses Akismet to reduce spam. Learn how your comment data is processed.